A breakthrough in non-invasive cancer treatment that uses your body’s own biology to fight tumors — safely, selectively, and effectively.
Targeted Osmotic Lysis of Highly Invasive Breast Carcinomas Using Pulsed Magnetic Field Stimulation of Voltage-Gated Sodium Channels and Pharmacological Blockade of Sodium Pumps – See Article >
Selective lysis of breast carcinomas by simultaneous stimulation of sodium channels and blockade of sodium pumps – See Article >
Targeted Osmotic Lysis: A Novel Approach to Targeted Cancer Therapies – See Article >
The Role of Targeted Osmotic Lysis in the Treatment of Advanced Carcinoma in Companion Animals: A Case Series – See Article >
Cancer as a Channelopathy – Appreciation of Complimentary Pathways Provides a Different Perspective for Developing Treatments – See Article >
Effect of Cell Cycle on Cell Surface Expression of Voltage-Gated Sodium Channels and Na⁺, K⁺ -ATPase – See Article >
In vitro Characterization of a novel murine model of cancerous progression – See Article >
Safety evaluation of targeted osmotic lysis therapy in Beagles – See Article >
Use of Targeted Osmotic Lysis for the Treatment of Malignant Melanoma: Case Report – See Article >
Use of Targeted Osmotic Lysis for the Treatment of Cutaneous Squamous Cell Carcinoma – See Article >
Advanced-stage cancer cells express 10 to 50 times more sodium channels in their cell membranes than do normal cells. By stimulating the opening of these channels and enabling the entry of large amounts of sodium while blocking the mechanism to expel the excess ions, Dr. Paul and Dr. Gould have been able to force cancer cells to burst, while leaving healthy cells unharmed. The treatment process uses a generic drug used to treat heart ailments (digoxin) and a new device that produces a pulsed electric field.